Anti-N-Methyl-D-Aspartate Receptor Encephalitis Clinical Trials in Beijing, Beijing Municipality

Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis